Chao Tu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- RNA modifications and cancer 21
- RNA Research and Splicing 11
- Circular RNAs in diseases 10
-
- Cancer-related molecular mechanisms research 21
- MicroRNA in disease regulation 9
- Co-authors
- Zhihong Li (76 shared papers)Lin Qi (30 shared papers)Chengyao Feng (24 shared papers)Jieyu He (13 shared papers)Wanchun Wang (11 shared papers)Zhongyue Liu (22 shared papers)Wenchao Zhang (19 shared papers)Binfeng Liu (16 shared papers)
- Journals
- Frontiers in Immunology (6 papers)Frontiers in Genetics (4 papers)Journal of Orthopaedic Surgery and Research (4 papers)Frontiers in Oncology (3 papers)Cancer Cell International (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Chao Tu
113 papers receiving 2.4k citations
Chao Tu's Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 417
- Infectious Diseases 380
- Biochemistry 97
- Molecular Biology 904
- Rheumatology 138
Countries citing papers authored by Chao Tu
This map shows the geographic impact of Chao Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Tu more than expected).
Fields of papers citing papers by Chao Tu
This network shows the impact of papers produced by Chao Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Tu. The network helps show where Chao Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chao Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 186 | |
| 2 | 2020 | 146 | |
| 3 | 2012 | 142 | |
| 4 | Nanomaterials for bone metastasis Hit paper breakdown → | 2024 | 114 |
| 5 | 2020 | 99 | |
| 6 | 2009 | 71 | |
| 7 | 2021 | 66 | |
| 8 | 2018 | 65 | |
| 9 | 2022 | 65 | |
| 10 | 2018 | 65 | |
| 11 | 2021 | 62 | |
| 12 | 2022 | 53 | |
| 13 | 2022 | 51 | |
| 14 | 2022 | 50 | |
| 15 | 2020 | 44 | |
| 16 | 2022 | 41 | |
| 17 | 2011 | 36 | |
| 18 | 2020 | 35 | |
| 19 | 2020 | 32 | |
| 20 | 2014 | 32 |
About Chao Tu
Chao Tu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 121 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (21 papers), RNA modifications and cancer (21 papers), Sarcoma Diagnosis and Treatment (16 papers), RNA Research and Splicing (11 papers), Circular RNAs in diseases (10 papers), MicroRNA in disease regulation (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Cancer Research (417 citations), Infectious Diseases (380 citations), Biochemistry (97 citations), Molecular Biology (904 citations) and Rheumatology (138 citations). Chao Tu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhihong Li, Lin Qi, Chengyao Feng, Jieyu He, Wanchun Wang, Zhongyue Liu, Wenchao Zhang, Binfeng Liu, Chenbei Li and Xiaolei Ren. Their work appears in journals such as Frontiers in Immunology, Frontiers in Genetics, Journal of Orthopaedic Surgery and Research, Frontiers in Oncology and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.